Moderna, Inc.
MRNA
NASDAQ
Weiss Ratings | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Weak | |||
Risk Index | Weak | |||
Risk Grade | D | |||
Reward Grade | D+ | |||
Rating Factors | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Index | -- | |||
Growth Index | Weak | |||
Efficiency Index | Fair | |||
Solvency Index | Excellent | |||
Total Return Index | Weak | |||
Volatility Index | Weak | |||
Beta / Standard Deviation | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 1.13 | |||
Price History | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | 3.00% | |||
30-Day Total Return | 21.91% | |||
60-Day Total Return | 5.79% | |||
90-Day Total Return | 51.77% | |||
Year to Date Total Return | -5.28% | |||
1-Year Total Return | -28.68% | |||
2-Year Total Return | -40.38% | |||
3-Year Total Return | -21.95% | |||
5-Year Total Return | 449.28% | |||
52-Week High % Change | -35.41% | |||
52-Week Low % Change | 68.55% | |||
Price | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
52-Week High Price | $163.24 | |||
52-Week Low Price | $62.55 | |||
52-Week Low Price (Date) | Nov 02, 2023 | |||
52-Week High Price (Date) | Apr 14, 2023 | |||
Valuation | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Market Cap | 40.37B | |||
Enterprise Value | 28.33B | |||
Price/Earnings (TTM) | -- | |||
Earnings Per Share (TTM) | -12.42 | |||
Earnings Per Share Growth | -162.14% | |||
Price/Earnings To Growth | -- | |||
Price/Sales (TTM) | 6.08 | |||
Price/Book (Q) | 2.91 | |||
Enterprise Value/Revenue (TTM) | 4.14 | |||
Price | $106.56 | |||
Enterprise Value/EBITDA (TTM) | -7.83 | |||
Enterprise Value/EBIT | -6.68 | |||
Market Cap Category | Large Cap | |||
Dividends and Shares | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Shares Outstanding | 395.00M | |||
Dividend Yield | -- | |||
Div. Per Share (Most Recent) | -- | |||
Dividend Per Share (TTM) | -- | |||
Payout Ratio (TTM) | -- | |||
Dividend Per Share (Most Recent) | -- | |||
Company Info | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Phone Number | 617 714 6500 | |||
Address | 200 Technology Square Cambridge, MA 02139 | |||
Website | www.modernatx.com | |||
Country | United States | |||
Year Founded | 2010 | |||
Profitability | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Operating Margin (TTM) | -61.90% | |||
Profit Margin | -68.83% | |||
Management Effectiveness | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Return on Assets | -11.97% | |||
Return on Equity | -- | |||
Income Statement | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Revenue (TTM) | 6.67B | |||
Total Revenue (TTM) | 6.85B | |||
Revenue Per Share | $17.34 | |||
Gross Profit (TTM) | -2.69B | |||
EBITDA (TTM) | -3.62B | |||
EBIT (TTM) | -4.24B | |||
Net Income (TTM) | -4.71B | |||
Net Income Avl. to Common (TTM) | -4.71B | |||
Total Revenue Growth (Q YOY) | -44.71% | |||
Earnings Growth (Q YOY) | -85.19% | |||
EPS Diluted (TTM) | -12.42 | |||
EPS Diluted Growth (Q YOY) | -85.11% | |||
Balance Sheet | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash and Short-Term Inv. (Q) | 8.60B | |||
Cash Per Share (Q) | $21.78 | |||
Total Current Assets (Q) | 10.33B | |||
Total Preferred Equity (Q) | -- | |||
Total Equity (Q) | 13.85B | |||
Current Ratio (Q) | 3.425 | |||
Book Value Per Share (Q) | $36.27 | |||
Total Assets (Q) | 18.43B | |||
Total Current Liabilities (Q) | 3.02B | |||
Total Debt (Q) | 1.24B | |||
Total Liabilities (Q) | 4.57B | |||
Total Common Equity (Q) | 13.85B | |||
Cash Flow | MRNA - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash from Investing (TTM) | 4.21B | |||
Cash from Financing (TTM) | -1.38B | |||
Net Change in Cash (TTM) | -289.00M | |||
Levered Free Cash Flow (TTM) | -2.38B | |||
Cash from Operations (TTM) | -3.12B | |||